FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4319007905> ?p ?o ?g. }

• W4319007905 abstract "Introduction: Ischemic stroke leads to prolonged reduction in brain pH. We previously found that G-protein coupled receptor 68 (GPR68), a proton-sensitive GPCR, mediates a neuroprotective pathway in brain ischemia. To investigate translational potential of GPR68 targeting, we examine here the effect of Ogerin, a positive allosteric modulator of GPR68, on ischemic brain injury. Methods: Using organotypic cortical slices, we examined the effect of Ogerin on signaling. Next, we induced oxygen-glucose deprivation (OGD) in slices and analyzed delayed neuronal injury at 24 hr with propidium iodide (PI) staining. Further, we performed transient middle cerebral artery occlusion (tMCAO) in WT and GPR68 knockout mice, treated them with vehicle or Ogerin, and analyzed brain infarct with TTC staining. We then assessed the effect of Ogerin on cerebral blood flow using Laser Speckle Imaging. Lastly, we performed immunostaining to determine the effect of Ogerin on neuroinflammation. Results: Ogerin induced phosphorylation of protein kinase C substrates in wild-type but not GPR68-/- slices. Ogerin (10 μM) reduced PI intake in OGD-treated slices, suggesting a reduced neuronal injury. Following tMCAO, intraperitoneal injection of Ogerin had no significant effect on brain infarct size. In contrast, Ogerin through intracerebroventricular injection (i.c.v) (0.25 mg/kg) significantly reduced brain infarct in WT (18.5 ± 11.8% (Ogerin) vs. 37.7 ± 7.2% (vehicle); p = 0.0043) but had no significant effect in GPR68-/- mice. Intravenous (i.v.) delivery of Ogerin at 3 & 1 mg/kg, but not at 0.3 mg/kg, significantly reduced brain infarct in WT. Moreover, delayed i.v delivery of Ogerin (1 mg/kg) at both 3 hours and 6 hours after reperfusion significantly reduced brain infarct. We further replicated the experiment in female mice, focusing on the metestrus stage. Ogerin through i.v (1 mg/kg) also reduced brain infarct in female mice. In parallel with the reduced brain infarct, Ogerin-treated mice exhibited a balanced (ipsilateral: contralateral) cerebral blood perfusion at 24 hour, and a reduced inflammatory response in microglia/macrophages. Conclusion: These data suggest that GPR68 potentiation with Ogerin is a promising neuroprotective reagent in brain ischemia." @default.
• W4319007905 created "2023-02-03" @default.
• W4319007905 creator A5027065648 @default.
• W4319007905 creator A5037476486 @default.
• W4319007905 creator A5085142676 @default.
• W4319007905 date "2023-02-01" @default.
• W4319007905 modified "2023-09-28" @default.
• W4319007905 title "Abstract 107: Potentiating GPR68 Function With Ogerin Protects Against Ischemic Brain Injury In Mice" @default.
• W4319007905 doi "https://doi.org/10.1161/str.54.suppl_1.107" @default.
• W4319007905 hasPublicationYear "2023" @default.
• W4319007905 type Work @default.
• W4319007905 citedByCount "0" @default.
• W4319007905 crossrefType "journal-article" @default.
• W4319007905 hasAuthorship W4319007905A5027065648 @default.
• W4319007905 hasAuthorship W4319007905A5037476486 @default.
• W4319007905 hasAuthorship W4319007905A5085142676 @default.
• W4319007905 hasConcept C126322002 @default.
• W4319007905 hasConcept C134018914 @default.
• W4319007905 hasConcept C157767197 @default.
• W4319007905 hasConcept C25498285 @default.
• W4319007905 hasConcept C2778820722 @default.
• W4319007905 hasConcept C42219234 @default.
• W4319007905 hasConcept C541997718 @default.
• W4319007905 hasConcept C71924100 @default.
• W4319007905 hasConcept C98274493 @default.
• W4319007905 hasConceptScore W4319007905C126322002 @default.
• W4319007905 hasConceptScore W4319007905C134018914 @default.
• W4319007905 hasConceptScore W4319007905C157767197 @default.
• W4319007905 hasConceptScore W4319007905C25498285 @default.
• W4319007905 hasConceptScore W4319007905C2778820722 @default.
• W4319007905 hasConceptScore W4319007905C42219234 @default.
• W4319007905 hasConceptScore W4319007905C541997718 @default.
• W4319007905 hasConceptScore W4319007905C71924100 @default.
• W4319007905 hasConceptScore W4319007905C98274493 @default.
• W4319007905 hasIssue "Suppl_1" @default.
• W4319007905 hasLocation W43190079051 @default.
• W4319007905 hasOpenAccess W4319007905 @default.
• W4319007905 hasPrimaryLocation W43190079051 @default.
• W4319007905 hasRelatedWork W1540517858 @default.
• W4319007905 hasRelatedWork W1974083985 @default.
• W4319007905 hasRelatedWork W1992468615 @default.
• W4319007905 hasRelatedWork W2027052432 @default.
• W4319007905 hasRelatedWork W2056690209 @default.
• W4319007905 hasRelatedWork W2070286483 @default.
• W4319007905 hasRelatedWork W2086628740 @default.
• W4319007905 hasRelatedWork W2092902246 @default.
• W4319007905 hasRelatedWork W2120631068 @default.
• W4319007905 hasRelatedWork W2124734881 @default.
• W4319007905 hasVolume "54" @default.
• W4319007905 isParatext "false" @default.
• W4319007905 isRetracted "false" @default.
• W4319007905 workType "article" @default.